Literature DB >> 21320076

Mast cells in health and disease.

Charlotte L Weller1, Sarah J Collington, Tim Williams, Jonathan R Lamb.   

Abstract

Although MCs (mast cells) were discovered over 100 years ago, for the majority of this time their function was linked almost exclusively to allergy and allergic disease with few other roles in health and disease. The engineering of MC-deficient mice and engraftment of these mice with MCs deficient in receptors or mediators has advanced our knowledge of the role of MCs in vivo. It is now known that MCs have very broad and varied roles in both physiology and disease which will be reviewed here with a focus on some of the most recent discoveries over the last year. MCs can aid in maintaining a healthy physiology by secreting mediators that promote wound healing and homoeostasis as well as interacting with neurons. Major developments have been made in understanding MC function in defence against pathogens, in recognition of pathogens as well as direct effector functions. Probably the most quickly developing area of understanding is the involvement and contribution MCs make in the progression of a variety of diseases from some of the most common diseases to the more obscure.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21320076     DOI: 10.1042/CS20100459

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  27 in total

1.  Mast cells infiltrate pancreatic islets in human type 1 diabetes.

Authors:  Luisa Martino; Matilde Masini; Marco Bugliani; Lorella Marselli; Mara Suleiman; Ugo Boggi; Tatiane C Nogueira; Franco Filipponi; Margherita Occhipinti; Daniela Campani; Francesco Dotta; Farooq Syed; Decio L Eizirik; Piero Marchetti; Vincenzo De Tata
Journal:  Diabetologia       Date:  2015-08-15       Impact factor: 10.122

2.  Mast cells cultured from IL-3-treated mice show impaired responses to bacterial antigen stimulation.

Authors:  Krisztina V Vukman; Tamás Visnovitz; Paul N Adams; Martin Metz; Marcus Maurer; Sandra M O'Neill
Journal:  Inflamm Res       Date:  2011-11-09       Impact factor: 4.575

3.  Bone marrow mast cell density correlates with serum levels of VEGF and CXC chemokines ENA-78 and GRO-α in multiple myeloma.

Authors:  C A Pappa; G Tsirakis; M Devetzoglou; M Zafeiri; R Vyzoukaki; A Androvitsanea; A Xekalou; K Sfiridaki; M G Alexandrakis
Journal:  Tumour Biol       Date:  2014-02-23

4.  Mast cell-macrophage dynamics in modulation of dengue virus infection in skin.

Authors:  Ya-Ting Chu; Shu-Wen Wan; Robert Anderson; Yee-Shin Lin
Journal:  Immunology       Date:  2015-07-14       Impact factor: 7.397

5.  Mast Cell Proteases Activate Astrocytes and Glia-Neurons and Release Interleukin-33 by Activating p38 and ERK1/2 MAPKs and NF-κB.

Authors:  Duraisamy Kempuraj; Ramasamy Thangavel; Gvindhasamy Pushpavathi Selvakumar; Mohammad Ejaz Ahmed; Smita Zaheer; Sudhanshu P Raikwar; Haris Zahoor; Daniyal Saeed; Iuliia Dubova; Gema Giler; Shelby Herr; Shankar S Iyer; Asgar Zaheer
Journal:  Mol Neurobiol       Date:  2018-06-18       Impact factor: 5.590

6.  BMP6-induced modulation of the tumor micro-milieu.

Authors:  David Stieglitz; Susanne Lamm; Simone Braig; Lena Feuerer; Silke Kuphal; Peter Dietrich; Stephanie Arndt; Bernd Echtenacher; Claus Hellerbrand; Sigrid Karrer; Anja-Katrin Bosserhoff
Journal:  Oncogene       Date:  2018-08-31       Impact factor: 9.867

7.  Stem cell factor programs the mast cell activation phenotype.

Authors:  Tomonobu Ito; Daniel Smrž; Mi-Yeon Jung; Geethani Bandara; Avanti Desai; Šárka Smržová; Hye Sun Kuehn; Michael A Beaven; Dean D Metcalfe; Alasdair M Gilfillan
Journal:  J Immunol       Date:  2012-04-23       Impact factor: 5.422

Review 8.  Manufactured and airborne nanoparticle cardiopulmonary interactions: a review of mechanisms and the possible contribution of mast cells.

Authors:  Jonathan H Shannahan; Urmila P Kodavanti; Jared M Brown
Journal:  Inhal Toxicol       Date:  2012-04       Impact factor: 2.724

9.  Chronic pelvic allodynia is mediated by CCL2 through mast cells in an experimental autoimmune cystitis model.

Authors:  Fuat Bicer; Cengiz Z Altuntas; Kenan Izgi; Ahmet Ozer; Michael Kavran; Vincent K Tuohy; Firouz Daneshgari
Journal:  Am J Physiol Renal Physiol       Date:  2014-09-10

10.  Pretreatment with glycomacropeptide reduces allergen sensitization, alleviates immediate cutaneous hypersensitivity and protects from anaphylaxis.

Authors:  M Jiménez; N A Chávez; E Salinas
Journal:  Clin Exp Immunol       Date:  2012-10       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.